Think | Create | Scale
Follow
  • Startup Pulse
    altM raises $10.3 million in a Series A round led by Rainmatter by Zerodha and Mela Ventures, with Omnivore, Theia Ventures, Aureolis Ventures, Spectrum Impact and strategic angel investors participating. Venomics AI raises $2.7 million in a pre-seed round co-led by Speciale Invest and South Park Commons, with Operators Studio participating. EloElo Group raises $80 million in a Series C round led by Hornbill Capital and NBCUniversal, with MIT Investment Co. and existing investors participating. Peppermint Robotics raises ₹100 crore (approximately $10.5 million) in a Pre-Series B round led by pi Ventures and Crane Venture Partners, with Asiana Fund participating. Traversal raises $120 million in a Series B round at a $1 billion valuation, led by Kleiner Perkins, Redpoint and Khosla Ventures, with Sequoia Capital, Battery Ventures and Amex Ventures participating. GIVA raises over $100 million in a round led by Multiples Alternate Asset Management. The Croffle Guys raises ₹14 crore in a round led by V3 Ventures, with N.A.N Partners participating. Solgram raises over $1 million in a pre-seed round led by DSG Consumer Partners and Saama Capital, with Kapil Chopra participating. Sachin Tendulkar makes a strategic investment in Metasports Interactive, the company behind Hitwicket. The amount was not disclosed. Hyeglo Beauty raises ₹7 crore in a round led by Sauce, with Giga Capital, Consumer Collective, Reckitt's Arjun Purkayastha and The Patient Capital participating. altM raises $10.3 million in a Series A round led by Rainmatter by Zerodha and Mela Ventures, with Omnivore, Theia Ventures, Aureolis Ventures, Spectrum Impact and strategic angel investors participating. Venomics AI raises $2.7 million in a pre-seed round co-led by Speciale Invest and South Park Commons, with Operators Studio participating. EloElo Group raises $80 million in a Series C round led by Hornbill Capital and NBCUniversal, with MIT Investment Co. and existing investors participating. Peppermint Robotics raises ₹100 crore (approximately $10.5 million) in a Pre-Series B round led by pi Ventures and Crane Venture Partners, with Asiana Fund participating. Traversal raises $120 million in a Series B round at a $1 billion valuation, led by Kleiner Perkins, Redpoint and Khosla Ventures, with Sequoia Capital, Battery Ventures and Amex Ventures participating. GIVA raises over $100 million in a round led by Multiples Alternate Asset Management. The Croffle Guys raises ₹14 crore in a round led by V3 Ventures, with N.A.N Partners participating. Solgram raises over $1 million in a pre-seed round led by DSG Consumer Partners and Saama Capital, with Kapil Chopra participating. Sachin Tendulkar makes a strategic investment in Metasports Interactive, the company behind Hitwicket. The amount was not disclosed. Hyeglo Beauty raises ₹7 crore in a round led by Sauce, with Giga Capital, Consumer Collective, Reckitt's Arjun Purkayastha and The Patient Capital participating.

    • Just In

    Park Medi World IPO to Open on December 10; Price Band Set at INR 154-162

    Latest News Posted on  —by Salil Urunkar

    Share

    Park Medi World IPO

    The Park Medi World IPO is scheduled to open for public subscription on Wednesday, December 10, 2025, with the issue closing on Friday, December 12, 2025. The Anchor Investor Bidding Date for the Park Medi World IPO has been set for Tuesday, December 9, 2025.

    Park Medi World IPO: Key Details and Price Band

    The Park Medi World IPO features a total issue size of ₹9,200 million (₹920 crore). This includes a fresh issue of equity shares worth ₹7,700 million (₹770 crore) and an Offer for Sale (OFS) of ₹1,500 million (₹150 crore) by promoter selling shareholder Dr Ajit Gupta.

    Also Read: Symbiosis Medtronic Experience Centre Launched in Pune to Advance Clinical Training

    The price band for the IPO has been fixed at ₹154 to ₹162 per equity share with a face value of ₹2.

    Investors can bid for a minimum of 92 equity shares and in multiples of 92 thereafter.

    Park Medi World IPO: Utilisation of Fresh Issue Proceeds

    The Park Medi World IPO will channel funds from the fresh issue toward several strategic purposes. These include repayment or prepayment of borrowings taken by the company and its subsidiaries, capital expenditure for establishing a new hospital under the subsidiary Park Medicity (NCR), procurement of medical equipment for the company and subsidiaries Blue Heavens and Ratangiri, and financing unidentified inorganic acquisitions along with general corporate requirements.

    Also Read: Fetal Medicine Conference: Experts Highlight Breakthroughs in Early Diagnosis at KEM Hospital

    Offer for Sale Component

    The Offer for Sale portion of the Park Medi World IPO consists of equity shares worth ₹1,500 million (₹150 crore) being sold by the promoter selling shareholder, Dr. Ajit Gupta. This component enables partial dilution of promoter holdings while allowing public investors to participate in the company’s growth.

    Book Running Lead Managers and Listing Plans

    Nuvama Wealth Management Limited, CLSA India Private Limited, DAM Capital Advisors Limited, and Intensive Fiscal Services Private Limited are serving as the Book Running Lead Managers for the Park Medi World IPO.

    The equity shares are being offered through the red herring prospectus dated December 4, 2025, filed with the Registrar of Companies, Delhi and Haryana. Once allotted, the shares are proposed to be listed on both BSE and NSE.

    Author

    • Salil Urunkar

      Salil Urunkar is a senior journalist and the editorial mind behind Sahyadri Startups. With years of experience covering Pune’s entrepreneurial rise, he’s passionate about telling the real stories of founders, disruptors, and game-changers.

    Share

    Related Posts

    Sahyadri Startups
    Copyright © 2026. All rights reserved. Powered by Rumanvay Growth Partners LLP Powered by Probewise.
    Back to top